Rachel Meyers
Keine laufenden Positionen mehr
Profil
Rachel Meyers is the founder of Faze Medicines, Inc. She is currently an Independent Director at Korro Bio, Inc. since 2023.
Previously, she worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. from 1993 to 2003.
Additionally, she held the position of Vice President-Research & RNAi Lead Discovery at Alnylam Pharmaceuticals, Inc. from 2011 to 2013.
Dr. Meyers obtained a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Brandeis University.
Aktive Positionen von Rachel Meyers
Unternehmen | Position | Beginn |
---|
Ehemalige bekannte Positionen von Rachel Meyers
Unternehmen | Position | Ende |
---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2003 |
Faze Medicines, Inc. | Gründer | - |
ALNYLAM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rachel Meyers
Massachusetts Institute of Technology | Doctorate Degree |
Brandeis University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Faze Medicines, Inc. |